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ABSTRACT
Objective To summarise studies describing incidence 
of sudden cardiac death in a general population of young 
individuals to inform screening policy.
Design Systematic review.
Data sources Database searches of MEDLINE, EMBASE 
and the Cochrane library (all inception to current) on 29 
April 2019 (updated 16 November 2019), and forward/
backward citation tracking of eligible studies.
Study eligibility criteria All studies that reported 
incidence of sudden cardiac death in young individuals 
(12–39 years) in a general population, with no restriction 
on language or date. Planned subgroups were incidence 
by age, sex, race and athletic status (including military 
personnel).
Data extraction Two reviewers independently assessed 
study eligibility, extracted study data and assessed risk 
of bias using the Joanna Briggs Institute critical appraisal 
checklist for prevalence studies.
Analysis Reported incidence of sudden cardiac death in 
the young per 100 000 person- years.
Results 38 studies that reported incidence across five 
continents. We identified substantial heterogeneity in 
population, sudden cardiac death definition, and case 
ascertainment methods, precluding meta- analysis. 
Median reported follow- up years was 6.97 million (IQR 
2.34 million–23.70 million) and number of sudden 
cardiac death cases was 64 (IQR 40–251). In the general 
population, the median of reported incidence was 1.7 
sudden cardiac death per 100 000 person- years (IQR 
1.3–2.6, range 0.75–11.9). Most studies (n=14, 54%) 
reported an incidence between one and two cases per 
100 000 person- years. Incidence was higher in males and 
older individuals.
Conclusions This systematic review identified variability 
in the reported incidence of sudden cardiac death in the 
young across studies. Most studies reported an incidence 
between one and two cases per 100 000 person- years.
PROSPERO registration number CRD42019120563.
INTRODUCTION
Cardiovascular disease is the leading cause 
of death worldwide.1 In the young, however, 
deaths due to cardiovascular disease are 
much less frequent than deaths due to other 
causes such as unintentional injury, suicide 
and homicide.2 Nevertheless, over 20 000 
young individuals aged under 45 die due 
to cardiovascular disease in the USA each 
year.3 The subgroup of young cardiovascular 
deaths that occur suddenly has a particularly 
profound effect on the individual’s family 
and local community.
Screening of asymptomatic individuals for 
cardiac conditions, such as cardiomyopathies 
and channelopathies, has been proposed as 
a strategy to reduce the incidence of sudden 
cardiac death in young people. The best 
evidence that such a strategy might be effec-
tive comes from a single Italian before- after 
study that reported a decreased incidence of 
sudden cardiac death in athletes following 
the introduction of a mandatory athlete 
screening programme.4 In view of the limita-
tions of the current evidence, screening of 
young asymptomatic non- athletes is not pres-
ently supported by either the American Heart 
Association or European Society of Cardi-
ology (AHA/ESC).5–7
For organisations that make decisions 
regarding the implementation of popula-
tion screening programmes, such as the 
US Preventive Services Task Force and UK 
National Screening Committee, a clear 
understanding of the incidence of the target 
condition provides important context for 
decision- making.8 9 In particular, incidence 
Strengths and limitations of this study
 ► This systematic review is reported in accordance 
with the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses checklist.
 ► We identified studies that reported the incidence of 
sudden cardiac death in the young through searches 
of key databases and citation tracking.
 ► All eligible studies were included, irrespective of the 
publication date or publication language.
 ► We identified and described variability in the defini-
tion of sudden cardiac death and methods used to 
identify sudden cardiac death across studies.
 ► We did not include cases of out- of- hospital cardiac 
arrest with successful resuscitation.
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is an indicator of the size of the health problem, and 
maximum benefit which could be gained from screening, 
to be balanced against the potential harms such as stop-
ping young people from participating in the exercise. 
Previous reviews of sudden cardiac death incidence have 
focused on the incidence across all ranges, or in specific 
populations.10 11 The aim of this systematic review is to 
describe current evidence on the incidence of sudden 
cardiac death in the young.
METHODS
We conducted a systematic review of studies that report 
the incidence of sudden cardiac death in the young. 
We were originally commissioned by the UK National 
Screening Committee to undertake a rapid review of inci-
dence studies.12 We subsequently chose to develop the 
rapid review into this systematic review, with no limitation 
on study location, date or publication language.
The review is written in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
guidelines.13
Search and study selection
We searched MEDLINE (1946–current), EMBASE (1947–
current) and the Cochrane library (inception–current) 
for eligible studies. The search strategy was developed 
by an information scientist. We used a combination of 
keywords and MESH terms to describe the population 
(eg, young adult, adolescent), condition (eg, sudden 
death, sudden cardiac death) and study type (eg, cohort, 
longitudinal) of interest. An example search strategy is 
included in the electronic supplement.
Following searches and duplicate removal, two reviewers 
independently screened study titles and abstracts. 
Conflicts were resolved through discussion or, where 
needed, arbitration by a third reviewer. The same process 
was adopted for review of full- text papers. We identified 
additional studies through forward and backward citation 
tracking of included studies.
Study eligibility criteria
We included studies that described the incidence (per 
100 000 person- years) of sudden cardiac death in the 
young, or that provided sufficient data to allow calcula-
tion of the incidence. We defined a young individual as 
someone aged 12–39 years. This age range reflects the 
target group for a sudden cardiac death programme that 
was recently considered by the UK National Screening 
Committee.12 The lower age cut- off of 12 years was used 
in the Italian sudden cardiac death screening study.4 
For reasons of pragmatism, we included studies where 
the reported incidence combined individuals in our 
target age range with younger individuals (≥1 year). 
Exclusion of individuals under 1 year avoided the risk of 
conflating sudden cardiac death with sudden infant death 
syndrome. We excluded studies where the reported inci-
dence combined individuals in our target age range with 
older individuals (≥40 years), due to the marked increase 
in sudden cardiac death incidence from the age of 40.14
We also excluded studies that reported incidence only 
in a population with previously known disease, or only 
included deaths that occurred at certain times of day 
(eg, at work or school) or during specific activities (eg, 
sports). We imposed no restriction on language or publi-
cation date. We did not mandate a specific definition of 
sudden cardiac death or case- ascertainment process, but 
these were recorded during data extraction and consid-
ered in the risk of bias assessments.
Our main population of interest was the general popu-
lation aged 12–39. To be included in the main analysis, 
studies were required to report incidence in a general 
population that included males and females with an age 
group that spanned at least ten- years between 12 and 
39 years. Where studies reported more than one age 
subgroup (eg, 12–21 years; 22–31 years), we selected 
the subgroup closest to the age of mid- late teens to be 
included in the main analysis. Our planned subgroups 
included incidence by age, sex, race and athletic status 
(including military personnel). We do not report 
subgroups of subgroups (eg, athletes broken down by 
sex).
Data extraction and analysis
We used a piloted pro forma to extract population charac-
teristics, study design case identification methods, use of 
systematic screening and outcome data. We assessed risk 
of bias using the Joanna Briggs Institute critical appraisal 
checklist for prevalence studies.15 We developed review- 
specific criteria for each checklist question. Two reviewers 
independently extracted data and assessed risk of bias, 
with discrepancies resolved through discussion. Papers 
published in a language other than English were trans-
lated by a fluent speaker.
We extracted incidence per 100 000 person- years and 
associated 95% CI from the papers. Where these data 
were not reported, we calculated them from the reported 
number of sudden cardiac deaths and person follow- up 
years. We computed the 95% CI based on a binomial 
distribution, using Stata V.15.1. Clinical heterogeneity in 
relation to population characteristics and case ascertain-
ment methods precluded pooling of data.
Patient/ and public involvement
We did not involve patients or members of the public in 
setting the research question, designing the study, under-
taking the study, the interpretation of the results or study 
write- up.
RESULTS
We performed initial database searches on 29 April 2019, 
and updated searches on 16 November 2019. Through 
searches and citation tracking, we identified 8360 unique 
citations of which we reviewed the full- text of 238. We 
excluded 27 of the 65 papers initially included due to 
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substantial or complete data overlap with other studies 
(figure 1).
Most of the 38 included studies4 16–52 were undertaken 
in Europe (n=20, 53%) and North America (n=14, 37%) 
(table 1). The majority were retrospective studies (n=29, 
76%). Median number of deaths and person follow- up 
years were 64 (IQR 40–251) and 6.97 million (IQR 2.34 
million–23.70 million), respectively. Study duration 
ranged from 1 year to 41 years.
There was variability in the population, case ascer-
tainment methods, and sudden cardiac death definition 
used between studies. This methodological heteroge-
neity precluded meta- analysis. Only nine studies (24%) 
stated that they used the AHA/ESC definition of sudden 
cardiac death. Our risk of bias assessment found that 
most studies were at high risk of bias. (figure 2; online 
supplemental table S1) As shown in figure 2, the main 
factor contributing to a high risk of bias was the method 
used to identify cases of sudden cardiac death. In five 
(13%) studies, sudden cardiac death was identified using 
death certificates. The remaining studies used a range 
of approaches that typically incorporated autopsy data to 
some extent.
Our main analysis included 26 studies (figure 3). The 
median of reported incidence was 1.7 sudden cardiac 
death per 100 000 person- years (IQR 1.3–2.6, range 
0.75–11.9). Of the 26 studies, 17 (65%) reported an inci-
dence of less than two sudden cardiac death events per 
100 000 person- years, and 14 (54%) studies reported an 
incidence between one and two cases per 100 000 person- 
years. All four studies reporting an incidence over three 
cases per 100 000 person- years were at high risk of bias 
across multiple domains.
Geographically, incidence appeared highest in African 
and Asian countries, although this may in part reflect the 
case ascertainment process and associated risk of bias. 
These studies also tended to include only older individ-
uals (≥18 years).
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses flow chart of study selections. SCD, sudden 
cardiac death.
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For our subgroup analysis, sex, age, athletic status and 
race were reported in 13, 11, 9 and 1 studies, respectively. 
We observed a consistently higher incidence in males 
(figure 4). In males, median incidence was 2.7 sudden 
cardiac death per 100 000 person- years (IQR 1.8–4.4, 
range 1.3–36), compared with a median incidence in 
females of 0.9 cases per 100 000 person- years (IQR 0.6–
1.4, range 0–7.0).
The use of different age cut- offs within studies made 
a comparison between studies on the association of inci-
dence of sudden cardiac death with age challenging 
(online supplemental figure S1).
Incidence in military personnel was reported in three 
studies and appeared to be consistently higher than in 
other populations (online supplemental figure S2). All 
three studies were undertaken in American military 
personnel and reported that individuals received pre- 
enrolment screening for cardiac conditions. We did not 
observe a clear difference in incidence between athletic 
and non- athletic populations. The highest incidence was 
reported in a prospective study of screened UK soccer 
players, although the low number of sudden cardiac 
deaths (eight events) means that the estimate of the inci-
dence is imprecise.
Figure 2 Risk of bias assessment.
Figure 3 Incidence of sudden cardiac death in general population. Range following study name indicates population age 
range.
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Race was reported in a single American study which 
broke incidence down into four categories (African Amer-
ican, White, Hispanic, other). Incidence was highest in 
the African- American population (online supplemental 
figure S3).
DISCUSSION
In this systematic review, we included 38 studies from five 
continents that reported the incidence of sudden cardiac 
death in young individuals. We identified significant 
variability in the reported incidence across studies. In 
our main analysis, most studies reported an incidence of 
between one and two sudden cardiac deaths per 100 000 
person- years, although reported incidence ranged from 
0.75 to 11.9 cases per 100 000 person- years. This variability 
may reflect differences in population, case- ascertainment 
methods, and definition used for sudden cardiac death. 
In predefined subgroups, we observed that male sex 
and increasing age seem to be associated with increased 
incidence.
Strengths and weaknesses of the study
The key strength of this review was the systematic iden-
tification and synthesis of 38 studies from a wide range 
of settings. We did not restrict inclusion by date and 
language, with fluent speakers used for translation.
Our review has four key limitations. First, while the 
geographical area covered by index studies was often 
large with a long recruitment period, the median number 
of sudden cardiac deaths identified per study was 64 
cases. The method used to identify sudden cardiac death 
was often sub- optimal, such that misclassification bias may 
have significantly impacted the reported incidence in 
some studies.53 Second, heterogeneity between studies in 
terms of the population and case ascertainment method 
used precluded meta- analysis. Thirdly, particularly for 
sub- groups, studies often described only the absolute inci-
dence, and did not provide sufficient additional data to 
calculate the 95% CI. As such, we could not describe the 
precision of the incidence rate in many studies. Finally, 
we limited our condition of interest to sudden cardiac 
death, and did not examine incidence of sudden cardiac 
arrest. While survival after sudden cardiac arrest is associ-
ated with important morbidity, the standard Utstein cate-
gorisation of cardiac arrest cause encompasses all medical 
causes, of which cardiac causes are only a subset.54 55
Comparison with other studies
Our review builds on two previous systematic reviews that 
described sudden cardiac death incidence across all age 
groups or in specific groups of young individuals.10 11 In 
line with our review findings, these reviews reported issues 
across index studies in relation to variability in reported 
incidence, use of different definitions of sudden cardiac 
death and use of different methods to identify cases of 
sudden cardiac death.
Variability in reported incidence reflects in part, the 
challenge of accurately identifying cases of sudden 
cardiac death. The method used to identify deaths varied 
across studies, although most used administrative data 
sources. Nevertheless, the inclusion of some patient 
groups, such as in- hospital deaths in patients admitted 
for a minor procedure, may have varied across studies. 
The definition of sudden cardiac death is based on 
both the circumstances and cause of death, such that 
classification requires knowledge of the cause of death 
and events leading up to the death.5 6 Only nine studies 
used the ESC/AHA definition of sudden cardiac death. 
Other studies either predated this definition of sudden 
cardiac death or adopted a different definition to fit the 
method used to identify cases of sudden cardiac death. 
Death certificate data provide an efficient way to estimate 
sudden cardiac death incidence. However, their use typi-
cally precludes the use of the AHA/ESC definition of 
sudden cardiac death as the certificate does not include 
information on the circumstances of the death. As such, 
studies relying on death certificate data likely overesti-
mate sudden cardiac death incidence.19
Figure 4 Incidence of sudden cardiac death in general population- sex subgroups.
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Determination of the cause of sudden cardiac death 
usually requires an autopsy, ideally by a specialist patholo-
gist.56 57 In included studies, reporting of the proportion 
of patients that received an autopsy and type of autopsy 
performed was often unclear. This is reflected in our risk 
of bias assessments. The decision to undertake an autopsy 
in a specific case may be influenced by factors such as 
the legal requirement for an autopsy, family acceptance 
of autopsy and the identification of a likely cause of death 
without autopsy. A recent European study reported an 
autopsy rate in young sudden death of less than 50%.45 
Where autopsy is not used, cause of death may be misclas-
sified, although the impact of this misclassification on 
overall incidence is uncertain. In some cases, cause of 
death may remain uncertain even after autopsy. In these 
cases, genetic testing of the deceased may be informative 
in determining both the cause of death and the need 
for cardiac screening of the victim’s family.17 57 58 In an 
Australasian study, genetic testing of 113 cases of unex-
plained sudden cardiac death cases identified cardiac 
gene variants that were definitely or probably pathogenic 
in over a quarter of cases.17
Studies included in this review spanned a 66- year period 
(1950–2016), although most studies report data collected 
since 2000. Recent observational studies provide evidence 
of a decreasing incidence of sudden cardiac death.25 42 59 
A Danish study reported a 3% average annual decrease 
in sudden cardiac death incidence between 2000 and 
2009.59 Potential explanations for this decrease include 
improved investigation of inherited cardiac disease, 
public health strategies to deal with obesity and smoking, 
and improved response to out- of- hospital cardiac arrest.
Clinical and policy implications
The decision to implement screening programmes in 
both the UK and USA requires evidence that the bene-
fits of screening outweigh its harms.9 60 Disease incidence 
data provides important context for evaluating evidence, 
particularly in the absence of direct evidence of benefit 
from randomised controlled trials. In less common 
conditions, a key concern are the potential harms that 
may result from false- positive results, and overdiagnosis 
of disease which may never become symptomatic. Never-
theless, rare disease may still meet criteria for population- 
based screening conditions, such as maple syrup urine 
disease in newborns.61
The incidence of a condition describes the number 
of individuals that might benefit from screening. In 
practice, however, not all young individuals that sustain 
sudden cardiac death have the potential to benefit from 
screening.
First, to be effective, screening must reliably identify 
individuals with disease. In this context, screening must 
detect a range of structural and electrical cardiac disease. 
The optimal screening strategy remains uncertain. A 
wide range of strategies have been described, ranging 
from those that comprise only a physical examination or 
medical history to more detailed assessments that include 
a 12- lead ECG.12 62 In programmes where a 12- lead ECG 
is collected, a number of assessment criteria have been 
developed to determine the need for follow- up testing.63–65 
In a prospective cohort study of 11 168 screened teenage 
footballers in which screening incorporated a physical 
examination, health questionnaire, echocardiogram and 
12- lead ECG, six out of eight individuals who subsequently 
experienced sudden cardiac death did not have disease 
detected at screening.23 This highlights a key challenge 
for policy makers in that, even if they decide to support 
a screening programme, detailed consideration will need 
to be given to the screening process and both the finan-
cial implications and individual harm that may stem from 
false- negatives and false- positive screening results.66 67
Second, population- level screening is targeted at 
asymptomatic individuals without a family history of 
sudden cardiac death. The incidence of sudden cardiac 
death reported in index studies included both asymp-
tomatic low- risk individuals and individuals at increased 
risk of sudden cardiac death who, in some countries, 
may already have access to screening.6 68–73 A recent study 
suggested that around one- third of young individuals 
experienced warning symptoms in the month preceding 
their sudden cardiac death, indicating the need for clini-
cians to consider cardiological investigations in symp-
tomatic young individuals.74 Examples of individuals at 
increased risk of sudden cardiac death include those with 
diagnosed cardiac disease, asymptomatic individuals with 
a family history of sudden cardiac death and symptom-
atic individuals without diagnosed cardiac disease. As 
such, policy makers need to be cognisant that incidence 
reported in population- based studies will overestimate 
the potential benefit of screening programmes which are 
targeted at low- risk asymptomatic individuals.
Finally, effective screening relies on the individ-
uals willingness to be screened. To date, most studies 
report screening which, while technically voluntary, was 
mandated for participation in an activity, such as sport. 
Studies of athletes report young people are supportive 
of screening.75 76 In practice, however, uptake of school- 
based cardiac screening programmes varies from 56% to 
79%, with substantial variation by year and school.77 78
In conclusion, studies of incidence of sudden cardiac 
death in young individuals have produced varying esti-
mates of the incidence, although most studies report the 
incidence to be between one and two cases per 100 000 
person- years. In these studies of young individuals, inci-
dence was highest in males and among older individuals.
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